Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE20-006: Research Grants To Prevent Firearm-Related Violence and Injuries; Amended Notice of Meeting, 35655 [2020-12654]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 113 / Thursday, June 11, 2020 / Notices
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
The current clearance was approved on
November 3, 2017 (OMB Control
Number 0935–0179) and will expire on
November 30, 2020.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
Below we provide AHRQ’s projected
average annual estimates for the next
three years:
Current Actions: New collection of
information.
Type of Review: New Collection.
Affected Public: Individuals and
Households, Businesses and
Organizations, State, Local or Tribal
Government.
Average Expected Annual Number of
Activities: 10.
Respondents: 10,900.
VerDate Sep<11>2014
17:33 Jun 10, 2020
Jkt 250001
Annual responses: 10,900.
Frequency of Response: Once per
request.
The total number of respondents
across all 10 activities in a given year is
10,900.
Average minutes per response: 19.
Burden hours: 3,383.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
35655
Firearm-Related Violence and Injuries;
July 6–10, 2020, 8:30 a.m.–5:00 p.m.,
EDT, Videoconference which was
published in the Federal Register on
June 1, 2020, Volume 85, Number 105,
page 33159. The meeting is being
amended to include specific dates and
times of the panels. CE20–006: Research
Grants to Prevent Firearm-Related
Violence and Injuries—Panel A will be
held July 6–7, 2020 from 8:30 a.m.–5:00
p.m., EDT. CE20–006: Research Grants
to Prevent Firearm-Related Violence and
Injuries—Panel B1 and Panel B2 will be
held July 8–10, 2020 from 8:30 a.m.–
5:00 p.m., EDT. The meeting is closed
to the public.
FOR FURTHER INFORMATION CONTACT:
Mikel Walters, Ph.D., Scientific Review
Official, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–12654 Filed 6–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 5, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–12582 Filed 6–10–20; 8:45 am]
BILLING CODE 4160–90–P
Centers for Medicare & Medicaid
Services
[CMS–7058–N]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of the Advisory Panel
on Outreach and Education (APOE)
June 25, 2020 Meeting
Centers for Disease Control and
Prevention
AGENCY:
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE20–006:
Research Grants To Prevent FirearmRelated Violence and Injuries;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—CE20–
006: Research Grants to Prevent
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
This notice announces the
next meeting of the APOE (the Panel) in
accordance with the Federal Advisory
Committee Act. The Panel advises and
makes recommendations to the
Secretary of the U.S. Department of
Health and Human Services (HHS) and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
opportunities to enhance the
SUMMARY:
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 85, Number 113 (Thursday, June 11, 2020)]
[Notices]
[Page 35655]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12654]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--CE20-006: Research Grants To Prevent Firearm-
Related Violence and Injuries; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--CE20-006: Research Grants to Prevent Firearm-Related Violence
and Injuries; July 6-10, 2020, 8:30 a.m.-5:00 p.m., EDT,
Videoconference which was published in the Federal Register on June 1,
2020, Volume 85, Number 105, page 33159. The meeting is being amended
to include specific dates and times of the panels. CE20-006: Research
Grants to Prevent Firearm-Related Violence and Injuries--Panel A will
be held July 6-7, 2020 from 8:30 a.m.-5:00 p.m., EDT. CE20-006:
Research Grants to Prevent Firearm-Related Violence and Injuries--Panel
B1 and Panel B2 will be held July 8-10, 2020 from 8:30 a.m.-5:00 p.m.,
EDT. The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific
Review Official, National Center for Injury Prevention and Control,
CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, Georgia 30341,
Telephone (404) 639-0913, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-12654 Filed 6-10-20; 8:45 am]
BILLING CODE 4163-18-P
